Neuropathic cancer pain: What we are dealing with? How to manage it?

References

• MerskeyHBogdukNClassification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms2nd edSeattleIASP2012
   Google Scholar
• BaranowskiABergerRBuffingtonTClassification of chronic painBaranowskiA4th ed2012 Available from: http://www.iasp-pain.org/PublicationsNews/Content.aspx?ItemNumber=1673&navItemNumber=677Accessed August 11, 2013
   Google Scholar
• BjorgulKNovicoffWMSalehKJAmerican Society of Anesthesiologist Physical Status score may be used as a comorbidity index in hip fracture surgeryJ Arthroplasty201025Suppl 613413720537857
   PubMed Web of Science ®Google Scholar
• RiefWKaasaSJensenRNew proposals for the International Classification of Diseases-11 revision of pain diagnosesJ Pain201213430531622480770
   PubMed Web of Science ®Google Scholar
• PolomanoRCFarrarJTPain and neuropathy in cancer survivors. Surgery, radiation, and chemotherapy can cause pain; research could improve its detection and treatmentAm J Nurs2006106Suppl 3394716481851
   PubMedGoogle Scholar
• ChongMSBajwaZHDiagnosis and treatment of neuropathic painJ Pain Symptom Manage200325Suppl 5S4S1112694987
   PubMed Web of Science ®Google Scholar
• TreedeRDJensenTSCampbellJNNeuropathic pain: redefinition and a grading system for clinical and research purposesNeurology200870181630163518003941
   PubMed Web of Science ®Google Scholar
• AuretKSchugSAPain management for the cancer patient – current practice and future developmentsBest Pract Res Clin Anaesthesiol201327454556124267557
   PubMedGoogle Scholar
• SwarmRAAbernethyAPAnghelescuDLAdult cancer painJ Natl Compr Canc Netw2013118992102223946177
   PubMed Web of Science ®Google Scholar
• BaronRBinderAWasnerGNeuropathic pain: diagnosis, pathophysiological mechanisms, and treatmentLancet Neurol20109880781920650402
   PubMed Web of Science ®Google Scholar
• AttalNNeuropathic pain: mechanisms, therapeutic approach, and interpretation of clinical trialsContinuum201218116117522810075
   PubMedGoogle Scholar
• WoolfCJSalterMWNeuronal plasticity: increasing the gain in painScience200028854721765176910846153
   PubMed Web of Science ®Google Scholar
• SiqueiraSRAlvesBMalpartidaHMTeixeiraMJSiqueiraJTAbnormal expression of voltage-gated sodium channels Nav1.7, Nav1.3 and Nav1.8 in trigeminal neuralgiaNeuroscience2009164257357719699781
   PubMed Web of Science ®Google Scholar
• Dib-HajjSDBlackJAWaxmanSGVoltage-gated sodium channels: therapeutic targets for painPain Med20091071260126919818036
   PubMed Web of Science ®Google Scholar
• BahiaPKSuzukiRBentonDCA functional role for small-conductance calcium-activated potassium channels in sensory pathways including nociceptive processesJ Neurosci200525143489349815814779
   PubMed Web of Science ®Google Scholar
• TsudaMBeggsSSalterMWInoueKMicroglia and intractable chronic painGlia2013611556122740331
   PubMed Web of Science ®Google Scholar
• ChengKIWangHCChuangYTPersistent mechanical allodynia positively correlates with an increase in activated microglia and increased P-p38 mitogen-activated protein kinase activation in streptozotocin-induced diabetic ratsEur J Pain201418216217323868758
   PubMed Web of Science ®Google Scholar
• GoudasLCBlochRGialeli-GoudasMLauJCarrDBThe epidemiology of cancer painCancer Invest200523218219015813511
   PubMed Web of Science ®Google Scholar
• van den Beuken-van EverdingenMHde RijkeJMKesselsAGSchoutenHCvan KleefMPatijnJPrevalence of pain in patients with cancer: a systematic review of the past 40 yearsAnn Oncol20071891437144917355955
   PubMed Web of Science ®Google Scholar
• RaymentCHjermstadMJAassNNeuropathic cancer pain: prevalence, severity, analgesics and impact from the European Palliative Care Research Collaborative-Computerised Symptom Assessment studyPalliat Med201327871472123175513
   PubMed Web of Science ®Google Scholar
• FoleyKMAcute and chronic cancer pain syndromesHanksGChernyNIChristakisNAFallonMKaasaSPortenoyRKOxford Textbook of Palliative Medicine3rd edNew YorkOxford University Press2004298
   Google Scholar
• BennettMIRaymentCHjermstadMAassNCaraceniAKaasaSPrevalence and aetiology of neuropathic pain in cancer patients: a systematic reviewPain2012153235936522115921
   PubMed Web of Science ®Google Scholar
• NealAJQianMYClinchASLeBHOrthostatic hypotension secondary to CRMP-5 paraneoplastic autonomic neuropathyJ Clin Neurosci Epub10112013
   Web of Science ®Google Scholar
• PaiceJAMechanisms and management of neuropathic pain in cancerJ Support Oncol20031210712015352654
   PubMedGoogle Scholar
• UrchCEDickensonAHNeuropathic pain in cancerEur J Cancer20084481091109618492553
   PubMed Web of Science ®Google Scholar
• ChristoPJMazloomdoostDCancer pain and analgesiaAnn N Y Acad Sci2008113827829818837907
   PubMed Web of Science ®Google Scholar
• WodarskiRClarkAKGristJMarchandFMalcangioMGabapentin reverses microglial activation in the spinal cord of streptozotocin-induced diabetic ratsEur J Pain200913880781118977160
   PubMed Web of Science ®Google Scholar
• Di Cesare MannelliLPaciniABonacciniLZanardelliMMelloTGhelardiniCMorphologic features and glial activation in rat oxaliplatin-dependent neuropathic painJ Pain201314121585160024135431
   PubMed Web of Science ®Google Scholar
• DemirIESchornSSchremmer-DanningerEPerineural mast cells are specifically enriched in pancreatic neuritis and neuropathic pain in pancreatic cancer and chronic pancreatitisPloS One201383e6052923555989
   PubMed Web of Science ®Google Scholar
• DemirIESchaferKHTieftrunkEFriessHCeyhanGONeural plasticity in the gastrointestinal tract: chronic inflammation, neurotrophic signals, and hypersensitivityActa Neuropathol2013125449150923417735
   PubMed Web of Science ®Google Scholar
• WangKDemirIED’HaeseJGThe neurotrophic factor neurturin contributes toward an aggressive cancer cell phenotype, neuropathic pain and neuronal plasticity in pancreatic cancerCarcinogenesis201435110311324067900
   PubMed Web of Science ®Google Scholar
• MantyhPWClohisyDRKoltzenburgMHuntSPMolecular mechanisms of cancer painNat Rev Cancer20022320120911990856
   PubMed Web of Science ®Google Scholar
• DelaneyAFleetwood-WalkerSMColvinLAFallonMTranslational medicine: cancer pain mechanisms and managementBr J Anaesth20081011879418492671
   PubMed Web of Science ®Google Scholar
• ColvinLFallonMChallenges in cancer pain management – bone painEur J Cancer20084481083109018439817
   PubMed Web of Science ®Google Scholar
• CaraceniAMartiniCZeccaEBreakthrough pain characteristics and syndromes in patients with cancer pain. An international surveyPalliat Med200418317718315198130
   PubMed Web of Science ®Google Scholar
• WindebankAJGrisoldWChemotherapy-induced neuropathyJ Peripher Nerv Syst2008131274618346229
   PubMed Web of Science ®Google Scholar
• AntoineJCCamdessancheJPPeripheral nervous system involvement in patients with cancerLancet Neurol200761758617166804
   PubMed Web of Science ®Google Scholar
• KoikeHTanakaFSobueGParaneoplastic neuropathy: wide-ranging clinicopathological manifestationsCurr Opin Neurol201124550451021799410
   PubMed Web of Science ®Google Scholar
• SindicCJInfectious neuropathiesCurr Opin Neurol201326551051523945279
   PubMed Web of Science ®Google Scholar
• YawnBPGildenDThe global epidemiology of herpes zosterNeurology2013811092893023999562
   PubMed Web of Science ®Google Scholar
• FashnerJBellALHerpes zoster and postherpetic neuralgia: prevention and managementAm Fam Physician201183121432143721671543
   PubMed Web of Science ®Google Scholar
• GildenDNagelMACohrsRJMahalingamRThe variegate neurological manifestations of varicella zoster virus infectionCurr Neurol Neurosci Rep201313937423884722
   PubMed Web of Science ®Google Scholar
• KimSRKhanFTyringSKVaricella zoster: an update on current treatment options and future perspectivesExpert Opin Pharmacother2014151617124289750
   PubMed Web of Science ®Google Scholar
• AngaroneMEpidemiology and prevention of viral infections in patients with hematologic malignanciesInfect Disord Drug Targets2011111273321303338
   PubMedGoogle Scholar
• WeitzmanDShavitOSteinMCohenRChodickGShalevVA population based study of the epidemiology of herpes zoster and its complicationsJ Infect201367546346923872209
   PubMed Web of Science ®Google Scholar
• HabelLARayGTSilverbergMJThe epidemiology of herpes zoster in patients with newly diagnosed cancerCancer Epidemiol Biomarkers Prev2013221829023118142
   PubMed Web of Science ®Google Scholar
• Garzón-RodríguezCGLyrasLGayosoLOCancer-related neuropathic pain in out-patient oncology clinics: a European surveyBMC Palliat Care20131214124200014
   PubMed Web of Science ®Google Scholar
• FairchildAUnder-treatment of cancer painCurr Opin Support Palliat Care201041111520040878
   PubMedGoogle Scholar
• ShimozumaKOhashiYTakeuchiAFeasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02Support Care Cancer200917121483149119330359
   PubMed Web of Science ®Google Scholar
• KuroiKShimozumaKOhashiYProspective assessment of chemotherapy-induced peripheral neuropathy due to weekly paclitaxel in patients with advanced or metastatic breast cancer (CSP-HOR 02 study)Support Care Cancer20091781071108019089463
   PubMed Web of Science ®Google Scholar
• GiglioPGilbertMRNeurologic complications of cancer and its treatmentCurr Oncol Rep2010121505920425608
   PubMed Web of Science ®Google Scholar
• KaleyTJDeangelisLMTherapy of chemotherapy-induced peripheral neuropathyBr J Haematol2009145131419170681
   PubMed Web of Science ®Google Scholar
• Farquhar-SmithPChemotherapy-induced neuropathic painCurr Opin Support Palliat Care2011511721192267
   PubMedGoogle Scholar
• RoelofsRIHrusheskyWRoginJRosenbergLPeripheral sensory neuropathy and cisplatin chemotherapyNeurology19843479349386330613
   PubMed Web of Science ®Google Scholar
• AlbersJWChaudhryVCavalettiGDonehowerRCInterventions for preventing neuropathy caused by cisplatin and related compoundsCochrane Database Syst Rev20112CD00522821328275
   PubMed Web of Science ®Google Scholar
• ParkSBLinCSKrishnanAVGoldsteinDFriedlanderMLKiernanMCOxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathyBrain2009132Pt 102712272319745023
   PubMed Web of Science ®Google Scholar
• TaLEEspesetLPodratzJWindebankAJNeurotoxicity of oxaliplatin and cisplatin for dorsal root ganglion neurons correlates with platinum-DNA bindingNeurotoxicology2006276992100216797073
   PubMed Web of Science ®Google Scholar
• DormannAJGrunewaldTWigginghausBHuchzermeyerHGemcitabine-associated autonomic neuropathyLancet199835191036449500323
   PubMed Web of Science ®Google Scholar
• ReevesBNDakhilSRSloanJAFurther data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy: North Central Cancer Treatment Group trial N08C1Cancer2012118205171517822415454
   PubMed Web of Science ®Google Scholar
• LeeJJSwainSMPeripheral neuropathy induced by microtubule-stabilizing agentsJ Clin Oncol200624101633164216575015
   PubMed Web of Science ®Google Scholar
• HausheerFHSchilskyRLBainSBerghornEJLiebermanFDiagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathySemin Oncol2006331154916473643
   PubMed Web of Science ®Google Scholar
• GradisharWJKrasnojonDCheporovSSignificantly longer progression-free survival with nab-paclitaxel compared with docetaxel as first-line therapy for metastatic breast cancerJ Clin Oncol200927223611361919470941
   PubMed Web of Science ®Google Scholar
• GradisharWJTjulandinSDavidsonNPhase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancerJ Clin Oncol200523317794780316172456
   PubMed Web of Science ®Google Scholar
• de BonoJSOudardSOzgurogluMPrednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trialLancet201037697471147115420888992
   PubMed Web of Science ®Google Scholar
• VerstappenCCKoeppenSHeimansJJDose-related vincristine-induced peripheral neuropathy with unexpected off-therapy worseningNeurology20056461076107715781834
   PubMed Web of Science ®Google Scholar
• WeintraubMAddeMAVenzonDJSevere atypical neuropathy associated with administration of hematopoietic colony-stimulating factors and vincristineJ Clin Oncol19961439359408622042
   PubMed Web of Science ®Google Scholar
• LeghaSSVincristine neurotoxicity. Pathophysiology and managementMed Toxicol1986164214273540519
   PubMedGoogle Scholar
• DeAngelisLMPosnerJBSide effects of chemotherapyNeurologic Complications of Cancer2nd edNew YorkOxford University Press2009447
   Google Scholar
• MokhtarGMShaabanSYElbarbaryNSFayedWAA trial to assess the efficacy of glutamic acid in prevention of vincristine-induced neurotoxicity in pediatric malignancies: a pilot studyJ Pediatr Hematol Oncol201032859460020921909
   PubMed Web of Science ®Google Scholar
• ArgyriouAAMarmiroliPCavalettiGKalofonosHPEpothilone-induced peripheral neuropathy: a review of current knowledgeJ Pain Symptom Manage201142693194021621965
   PubMed Web of Science ®Google Scholar
• CortesJO’ShaughnessyJLoeschDEribulin monotherapy versus treatment of physician’s choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised studyLancet2011377976991492321376385
   PubMed Web of Science ®Google Scholar
• RajkumarSVRosinolLHusseinMMulticenter, randomized, double-blind, placebo-controlled study of thalidomide plus dexamethasone compared with dexamethasone as initial therapy for newly diagnosed multiple myelomaJ Clin Oncol200826132171217718362366
   PubMed Web of Science ®Google Scholar
• PlasmatiRPastorelliFCavoMNeuropathy in multiple myeloma treated with thalidomide: a prospective studyNeurology200769657358117679676
   PubMed Web of Science ®Google Scholar
• MurphyPTO’DonnellJRThalidomide induced impotence in male hematology patients: a common but ignored complication?Haematologica20079210144018024384
   PubMed Web of Science ®Google Scholar
• DimopoulosMAChenCSpencerALong-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myelomaLeukemia200923112147215219626046
   PubMed Web of Science ®Google Scholar
• RajkumarSVRichardsonPGHideshimaTAndersonKCProteasome inhibition as a novel therapeutic target in human cancerJ Clin Oncol200523363063915659509
   PubMed Web of Science ®Google Scholar
• GoyAYounesAMcLaughlinPPhase II study of proteasome inhibitor bortezomib in relapsed or refractory B-cell non-Hodgkin’s lymphomaJ Clin Oncol200523466767515613697
   PubMed Web of Science ®Google Scholar
• KobrinskyBJosephSOMuggiaFA phase I and pharmacokinetic study of oxaliplatin and bortezomib: activity, but dose-limiting neurotoxicityCancer Chemother Pharmacol20137251073107824048674
   PubMed Web of Science ®Google Scholar
• HarveyRDOwonikokoTKLewisCMA phase 1 Bayesian dose selection study of bortezomib and sunitinib in patients with refractory solid tumor malignanciesBr J Cancer2013108476276523322195
   PubMed Web of Science ®Google Scholar
• CavalettiGJakubowiakAJPeripheral neuropathy during bortezomib treatment of multiple myeloma: a review of recent studiesLeuk Lymphoma20105171178118720497001
   PubMed Web of Science ®Google Scholar
• RichardsonPGDelforgeMBeksacMManagement of treatment-emergent peripheral neuropathy in multiple myelomaLeukemia201226459560822193964
   PubMed Web of Science ®Google Scholar
• ChaudhryVCornblathDRPolydefkisMFergusonABorrelloICharacteristics of bortezomib- and thalidomide-induced peripheral neuropathyJ Peripher Nerv Syst200813427528219192067
   PubMed Web of Science ®Google Scholar
• LawasutPChauhanDLaubachJNew proteasome inhibitors in myelomaCurr Hematol Malig Rep20127425826623065395
   PubMed Web of Science ®Google Scholar
• SiegelDSMartinTWangMA phase 2 study of single-agent carfilzomib (PX-171-003-A1) in patients with relapsed and refractory multiple myelomaBlood2012120142817282522833546
   PubMed Web of Science ®Google Scholar
• DautRLCleelandCSFlaneryRCDevelopment of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseasesPain19831721972106646795
   PubMed Web of Science ®Google Scholar
• FishmanBPasternakSWallensteinSLHoudeRWHollandJCFoleyKMThe Memorial Pain Assessment Card. A valid instrument for the evaluation of cancer painCancer1987605115111583300951
   PubMed Web of Science ®Google Scholar
• BennettMIAttalNBackonjaMMUsing screening tools to identify neuropathic painPain2007127319920317182186
   PubMed Web of Science ®Google Scholar
• AttalNCruccuGBaronREFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revisionEur J Neurol20101791113118820402746
   PubMed Web of Science ®Google Scholar
• CleelandCSFarrarJTHausheerFHAssessment of cancer-related neuropathy and neuropathic painOncologist201015Suppl 2131820489192
   PubMed Web of Science ®Google Scholar
• CruccuGTruiniANeuropathic pain and its assessmentSurg Oncol201019314915420056406
   PubMed Web of Science ®Google Scholar
• BrzezińskiKChemotherapy-induced peripheral neuropathy. Part II. PreventionContemp Oncol (Pozn)201216325826123788891
   PubMed Web of Science ®Google Scholar
• RipamontiCISantiniDMaranzanoEBertiMRoilaFManagement of cancer pain: ESMO Clinical Practice GuidelinesAnn Oncol201223Suppl 7vii139vii15422997447
   PubMed Web of Science ®Google Scholar
• WalkerVAHoskinPJHanksGWWhiteIDEvaluation of WHO analgesic guidelines for cancer pain in a hospital-based palliative care unitJ Pain Symptom Manage1988331451492458415
   PubMedGoogle Scholar
• World Health OrganizationScoping document for WHO guidelines for the pharmacological treatment of persisting pain in adults with medical illnesses2012 Available from: http://www.who.int/medicines/areas/quality_safety/Scoping_WHO_GLs_PersistPainAdults_webversion.pdfAccessed October 8, 2013
   Google Scholar
• McNicolEStrasselsSAGoudasLLauJCarrDBNSAIDS or paracetamol, alone or combined with opioids, for cancer painCochrane Database Syst Rev20051CD00518015654708
   PubMed Web of Science ®Google Scholar
• NabalMLibradaSRedondoMJPigniABrunelliCCaraceniAThe role of paracetamol and nonsteroidal anti-inflammatory drugs in addition to WHO Step III opioids in the control of pain in advanced cancer. A systematic review of the literaturePalliat Med201226430531222126843
   PubMed Web of Science ®Google Scholar
• CaraceniAHanksGKaasaSUse of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPCLancet Oncol2012132e58e6822300860
   PubMed Web of Science ®Google Scholar
• LotschJOpioid metabolitesJ Pain Symptom Manage200529Suppl 5S10S2415907643
   PubMed Web of Science ®Google Scholar
• DuhmkeRMCornblathDDHollingsheadJRTramadol for neuropathic painCochrane Database Syst Rev20042CD00372615106216
   PubMedGoogle Scholar
• MercadanteSPorzioGFerreraPTapentadol in cancer pain management: a prospective open-label studyCurr Med Res Opin201228111775177923057488
   PubMed Web of Science ®Google Scholar
• KingSForbesKHanksGWFerroCJChambersEJA systematic review of the use of opioid medication for those with moderate to severe cancer pain and renal impairment: a European Palliative Care Research Collaborative opioid guidelines projectPalliat Med201125552555221708859
   PubMed Web of Science ®Google Scholar
• GaertnerJSchiesslCCancer pain management: what’s new?Curr Pain Headache Rep201317432823456796
   PubMed Web of Science ®Google Scholar
• AhmedzaiSHNauckFBar-SelaGBosseBLeyendeckerPHoppMA randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate/severe, chronic cancer painPalliat Med2012261506021937568
   PubMed Web of Science ®Google Scholar
• PaiceJAFerrellBThe management of cancer painCA Cancer J Clin201161315718221543825
   PubMed Web of Science ®Google Scholar
• MinozziSAmatoLDavoliMDevelopment of dependence following treatment with opioid analgesics for pain relief: a systematic reviewAddiction2013108468869822775332
   PubMed Web of Science ®Google Scholar
• FallonMHanksGChernyNPrinciples of control of cancer painBMJ200633275481022102416644831
   PubMed Web of Science ®Google Scholar
• GuindonJWalczakJSBeaulieuPRecent advances in the pharmacological management of painDrugs200767152121213317927280
   PubMed Web of Science ®Google Scholar
• KnotkovaHPappagalloMAdjuvant analgesicsMed Clin North Am200791111312417164107
   PubMed Web of Science ®Google Scholar
• FallonMTNeuropathic pain in cancerBr J Anaesth2013111110511123794652
   PubMed Web of Science ®Google Scholar
• DworkinRHO’ConnorABBackonjaMPharmacologic management of neuropathic pain: evidence-based recommendationsPain2007132323725117920770
   PubMed Web of Science ®Google Scholar
• HempenstallKNurmikkoTJJohnsonRWA’HernRPRiceASAnalgesic therapy in postherpetic neuralgia: a quantitative systematic reviewPLoS Med200527e16416013891
   PubMed Web of Science ®Google Scholar
• SaartoTWiffenPJAntidepressants for neuropathic pain: a Cochrane reviewJ Neurol Neurosurg Psychiatry201081121372137320543189
   PubMed Web of Science ®Google Scholar
• SindrupSHBachFWMadsenCGramLFJensenTSVenlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trialNeurology20036081284128912707430
   PubMed Web of Science ®Google Scholar
• RowbothamMCGoliVKunzNRLeiDVenlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled studyPain2004110369770615288411
   PubMed Web of Science ®Google Scholar
• DurandJPDeplanqueGMontheilVEfficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trialAnn Oncol201223120020521427067
   PubMed Web of Science ®Google Scholar
• DurandJPGoldwasserFDramatic recovery of paclitaxel-disabling neurosensory toxicity following treatment with venlafaxineAnticancer Drugs200213777778012187335
   PubMed Web of Science ®Google Scholar
• KajdaszDKIyengarSDesaiahDDuloxetine for the management of diabetic peripheral neuropathic pain: evidence-based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel-group studiesClin Ther200729Suppl2536254618164920
   PubMed Web of Science ®Google Scholar
• VevesABackonjaMMalikRAPainful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment optionsPain Med20089666067418828198
   PubMed Web of Science ®Google Scholar
• IrvingGAContemporary assessment and management of neuropathic painNeurology20056412 Suppl 3S21S2715999405
   PubMed Web of Science ®Google Scholar
• LunnMPHughesRAWiffenPJDuloxetine for treating painful neuropathy, chronic pain or fibromyalgiaCochrane Database Syst Rev20141CD00711524385423
   PubMed Web of Science ®Google Scholar
• AmrYMYousefAAEvaluation of efficacy of the perioperative administration of venlafaxine or gabapentin on acute and chronic postmastectomy painClin J Pain201026538138520473044
   PubMed Web of Science ®Google Scholar
• PiccoloJKolesarJMPrevention and treatment of chemotherapy-induced peripheral neuropathyAm J Health Syst Pharm2014711192524352178
   PubMed Web of Science ®Google Scholar
• SemenchukMRShermanSDavisBDouble-blind, randomized trial of bupropion SR for the treatment of neuropathic painNeurology20015791583158811706096
   PubMed Web of Science ®Google Scholar
• VadaloucaARaptisEMokaEZisPSykiotiPSiafakaIPharmacological treatment of neuropathic cancer pain: a comprehensive review of the current literaturePain Pract201212321925121797961
   PubMed Web of Science ®Google Scholar
• CaraceniAZeccaEBonezziCGabapentin for neuropathic cancer pain: a randomized controlled trial from the Gabapentin Cancer Pain Study GroupJ Clin Oncol200422142909291715254060
   PubMed Web of Science ®Google Scholar
• TsavarisNKopteridesPKosmasCGabapentin monotherapy for the treatment of chemotherapy-induced neuropathic pain: a pilot studyPain Med2008981209121619067834
   PubMed Web of Science ®Google Scholar
• AraiYCMatsubaraTShimoKLow-dose gabapentin as useful adjuvant to opioids for neuropathic cancer pain when combined with low-dose imipramineJ Anesth201024340741020217150
   PubMed Web of Science ®Google Scholar
• LossignolDAPlehiersBBodyJJGabapentin (Neurontin) and cancer pain: a pilot studyRev Med Brux2004255429435 French15584643
   PubMedGoogle Scholar
• MishraSBhatnagarSGoyalGNRanaSPUpadhyaSPA comparative efficacy of amitriptyline, gabapentin, and pregabalin in neuropathic cancer pain: a prospective randomized double-blind placebo-controlled studyAm J Hosp Palliat Care201229317718221745832
   PubMed Web of Science ®Google Scholar
• YanPZButlerPMKurowskiDPerloffMDBeyond neuropathic pain: gabapentin use in cancer pain and perioperative painClin J Pain EpubNovemer252013
   Web of Science ®Google Scholar
• RossJRWaightCRileyJBroadleyKGabapentin: resistant neuropathic pain and malignancyPalliat Med200115434834912054154
   PubMed Web of Science ®Google Scholar
• NavarroASaldañaMTPérezCTorradesSRejasJPatient-reported outcomes in subjects with neuropathic pain receiving pregabalin: evidence from medical practice in primary care settingsPain Med201011571973120345618
   PubMed Web of Science ®Google Scholar
• WiffenPJDerrySMooreRALamotrigine for chronic neuropathic pain and fibromyalgia in adultsCochrane Database Syst Rev201312CD00604424297457
   PubMed Web of Science ®Google Scholar
• ZakrzewskaJMMcMillanRTrigeminal neuralgia: the diagnosis and management of this excruciating and poorly understood facial painPostgrad Med J201187102841041621493636
   PubMed Web of Science ®Google Scholar
• OkonTKetamine: an introduction for the pain and palliative medicine physicianPain Physician200710349350017525784
   PubMedGoogle Scholar
• SindrupSHJensenTSEfficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug actionPain199983338940010568846
   PubMed Web of Science ®Google Scholar
• NoppersINiestersMAartsLSmithTSartonEDahanAKetamine for the treatment of chronic non-cancer painExpert Opin Pharmacother201011142417242920828267
   PubMed Web of Science ®Google Scholar
• HardyJQuinnSFazekasBRandomized, double-blind, placebo-controlled study to assess the efficacy and toxicity of subcutaneous ketamine in the management of cancer painJ Clin Oncol201230293611361722965960
   PubMed Web of Science ®Google Scholar
• JacksonKFrancoMWilliamLKetamine and cancer pain: the reports of my death have been greatly exaggeratedJ Clin Oncol201331101373137423423743
   PubMed Web of Science ®Google Scholar
• CrosbyVWilcockACorcoranRThe safety and efficacy of a single dose (500 mg or 1 g) of intravenous magnesium sulfate in neuropathic pain poorly responsive to strong opioid analgesics in patients with cancerJ Pain Symptom Manage2000191353910687324
   PubMed Web of Science ®Google Scholar
• SawynokJTopical analgesics for neuropathic pain: preclinical exploration, clinical validation, future developmentEur J Pain Epub9242013
   Web of Science ®Google Scholar
• ArgoffCEBarkinRLMcCarbergBStanosSPGalluzziKEArnstreinPMTopical analgesics in the management of acute and chronic painPostgrad Med20131254 Suppl 134124141026
   PubMedGoogle Scholar
• RowbothamMCDaviesPSVerkempinckCGalerBSLidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgiaPain199665139448826488
   PubMed Web of Science ®Google Scholar
• GalerBSRowbothamMCPeranderJFriedmanETopical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment studyPain199980353353810342414
   PubMed Web of Science ®Google Scholar
• MeierTWasnerGFaustMEfficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled studyPain20031061–215115814581122
   PubMed Web of Science ®Google Scholar
• ConnollyIZaleonCMontagniniMManagement of severe neuropathic cancer pain: an illustrative case and reviewAm J Hosp Palliat Care2013301839022504863
   PubMed Web of Science ®Google Scholar
• JonesVMMooreKAPetersonDMCapsaicin 8% topical patch (Qutenza) – a review of the evidenceJ Pain Palliat Care Pharmacother2011251324121426216
   PubMedGoogle Scholar
• HoySMTapentadol extended release: in adults with chronic painDrugs201272337539322316353
   PubMed Web of Science ®Google Scholar
• BuynakRShapiroDYOkamotoAEfficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo-and active-controlled Phase III studyExpert Opin Pharmacother201011111787180420578811
   PubMed Web of Science ®Google Scholar
• AfilaloMEtropolskiMSKuperwasserBEfficacy and safety of tapentadol extended release compared with oxycodone controlled release for the management of moderate to severe chronic pain related to osteoarthritis of the knee: a randomized, double-blind, placebo- and active-controlled phase III studyClin Drug Investig2010308489505
   PubMed Web of Science ®Google Scholar
• MerkerMDingesGKochTKrankePMorinAMUndesired side effects of tapentadol in comparison to oxycodone. A meta-analysis of randomized controlled comparative studiesSchmerz20122611626 German22366930
   PubMed Web of Science ®Google Scholar
• PortenoyRKGanae-MotanEDAllendeSNabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trialJ Pain201213543844922483680
   PubMed Web of Science ®Google Scholar
• PertweeRGCannabinoid pharmacology: the first 66 yearsBr J Pharmacol2006147Suppl 1S163S17116402100
   PubMed Web of Science ®Google Scholar
• WelchSPStevensDLAntinociceptive activity of intrathecally administered cannabinoids alone, and in combination with morphine, in miceJ Pharmacol Exp Ther1992262110181320680
   PubMed Web of Science ®Google Scholar
• DesrochesJBouchardJFGendronLBeaulieuPInvolvement of cannabinoid receptors in peripheral and spinal morphine analgesiaNeuroscience2014261234224365460
   PubMed Web of Science ®Google Scholar
• BeijersAJJongenJLVreugdenhilGChemotherapy-induced neurotoxicity: the value of neuroprotective strategiesNeth J Med2012701182522271810
   PubMed Web of Science ®Google Scholar
• MijnhoutGSAlkhalafAKleefstraNBiloHJAlpha lipoic acid: a new treatment for neuropathic pain in patients with diabetes?Neth J Med201068415816220421656
   PubMed Web of Science ®Google Scholar
• KalkanisJGWhitworthCRybakLPVitamin E reduces cisplatin ototoxicityLaryngoscope2004114353854215091231
   PubMed Web of Science ®Google Scholar
• KottschadeLASloanJAMazurczakMAThe use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trialSupport Care Cancer201119111769177720936417
   PubMed Web of Science ®Google Scholar
• BergerASadoskyADukesEEdelsbergJOsterGClinical characteristics and patterns of healthcare utilization in patients with painful neuropathic disorders in UK general practice: a retrospective cohort studyBMC Neurol201212822394606
   PubMed Web of Science ®Google Scholar
• GilronIJensenTSDickensonAHCombination pharmacotherapy for management of chronic pain: from bench to bedsideLancet Neurol201312111084109524074723
   PubMed Web of Science ®Google Scholar
• ChaparroLEWiffenPJMooreRAGilronICombination pharmacotherapy for the treatment of neuropathic pain in adultsCochrane Database Syst Rev20127CD00894322786518
   PubMed Web of Science ®Google Scholar
• GattiASabatoAFOcchioniRColini BaldeschiGRealeCControlled-release oxycodone and pregabalin in the treatment of neuropathic pain: results of a multicenter Italian studyEur Neurol200961312913719092248
   PubMed Web of Science ®Google Scholar
• FinnerupNBOttoMMcQuayHJJensenTSSindrupSHAlgorithm for neuropathic pain treatment: an evidence based proposalPain2005118328930516213659
   PubMed Web of Science ®Google Scholar
• GarassinoMCPivaSLa VerdeNRandomised phase II trial (NCT00637975) evaluating activity and toxicity of two different escalating strategies for pregabalin and oxycodone combination therapy for neuropathic pain in cancer patientsPloS One201384e5998123577077
   PubMed Web of Science ®Google Scholar
• NishiharaMAraiYCYamamotoYCombinations of low-dose antidepressants and low-dose pregabalin as useful adjuvants to opioids for intractable, painful bone metastasesPain Physician2013165E547E55224077205
   PubMed Web of Science ®Google Scholar
• LazzariMSabatoAFCaldaruloCEffectiveness and tolerability of low-dose oral oxycodone/naloxone added to anticonvulsant therapy for noncancer neuropathic pain: an observational analysisCurr Med Res Opin Epub1252013
   Web of Science ®Google Scholar
• BhaskarAKInterventional management of cancer painCurr Opin Support Palliat Care2012611922246043
   PubMed Web of Science ®Google Scholar
• PlancarteRGuajardo-RosasJReyes-ChiqueteDManagement of chronic upper abdominal pain in cancer: transdiscal blockade of the splanchnic nervesReg Anesth Pain Med201035650050620975463
   PubMed Web of Science ®Google Scholar
• ZhangWYLiZSJinZDEndoscopic ultrasound-guided ethanol ablation therapy for tumorsWorld J Gastroenterol201319223397340323801831
   PubMed Web of Science ®Google Scholar
• HarshVViswanathanASurgical/radiological interventions for cancer painCurr Pain Headache Rep201317533123512723
   PubMed Web of Science ®Google Scholar
• FalcoFJPatelVBHayekSMIntrathecal infusion systems for long-term management of chronic non-cancer pain: an update of assessment of evidencePain Physician201316Suppl 2SE185SE21623615891
   PubMedGoogle Scholar
• Sheinfeld GorinSKrebsPBadrHMeta-analysis of psychosocial interventions to reduce pain in patients with cancerJ Clin Oncol201230553954722253460
   PubMed Web of Science ®Google Scholar
• GarciaMKMcQuadeJHaddadRSystematic review of acupuncture in cancer care: a synthesis of the evidenceJ Clin Oncol201331795296023341529
   PubMed Web of Science ®Google Scholar
• MaaniCVShahMAHansenJJFowlerMMaaniEVMcGheeLLTranslational advances in pain and anesthesia for cancer patientsJ Surg Oncol2012105548849322441901
   PubMed Web of Science ®Google Scholar
• StamerUMStüberFCodeine and tramadol analgesic efficacy and respiratory effects are influenced by CYP2D6 genotypeAnaesthesia2007621212941295 author reply 1295–129617991273
   PubMed Web of Science ®Google Scholar
• StamerUMMusshoffFKobilayMMadeaBHoeftAStuberFConcentrations of tramadol and O-desmethyltramadol enantiomers in different CYP2D6 genotypesClin Pharmacol Ther2007821414717361124
   PubMed Web of Science ®Google Scholar
• TurabiAPlunkettARThe application of genomic and molecular data in the treatment of chronic cancer painJ Surg Oncol2012105549450122441902
   PubMed Web of Science ®Google Scholar
• WolfeDMataMFinkDJTargeted drug delivery to the peripheral nervous system using gene therapyNeurosci Lett20125272858922565023
   PubMed Web of Science ®Google Scholar
• XuJMSongSTFengFYCobrotoxin-containing analgesic compound to treat chronic moderate to severe cancer pain: results from a randomized, double-blind, cross-over study and from an open-label studyOncol Rep20061651077108417016596
   PubMed Web of Science ®Google Scholar
• WallaceMSKosekPSStaatsPFisherRSchultzDMLeongMPhase II, open-label, multicenter study of combined intrathecal morphine and ziconotide: addition of ziconotide in patients receiving intrathecal morphine for severe chronic painPain Med20089327128118366507
   PubMed Web of Science ®Google Scholar
• WallaceMSCharapataSGFisherRIntrathecal ziconotide in the treatment of chronic nonmalignant pain: a randomized, double-blind, placebo-controlled clinical trialNeuromodulation200692758622151630
   PubMed Web of Science ®Google Scholar
• StaatsPSYearwoodTCharapataSGIntrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trialJAMA20042911637014709577
   PubMed Web of Science ®Google Scholar
• EllisDJDissanayakeSMcGuireDContinuous intrathecal infusion of ziconotide for treatment of chronic malignant and nonmalignant pain over 12 months: a prospective, open-label studyNeuromodulation2008111404922150990
   PubMed Web of Science ®Google Scholar
• HannonHEAtchisonWDOmega-conotoxins as experimental tools and therapeutics in pain managementMar Drugs201311368069923470283
   PubMed Web of Science ®Google Scholar
• MarcilJWalczakJSGuindonJNgocAHLuSBeaulieuPAntinociceptive effects of tetrodotoxin (TTX) in rodentsBr J Anaesth200696676176816675510
   PubMed Web of Science ®Google Scholar
• PatelMKGonzalezMIBramwellSPinnockRDLeeKGabapentin inhibits excitatory synaptic transmission in the hyperalgesic spinal cordBr J Pharmacol200013081731173410952660
   PubMed Web of Science ®Google Scholar
• HagenNALapointeBOng-LamMA multicentre open-label safety and efficacy study of tetrodotoxin for cancer painCurr Oncol2011183e109e11621655148
   PubMed Web of Science ®Google Scholar
• HagenNAFisherKMLapointeBAn open-label, multi-dose efficacy and safety study of intramuscular tetrodotoxin in patients with severe cancer-related painJ Pain Symptom Manage200734217118217662911
   PubMed Web of Science ®Google Scholar
• HagenNAdu SouichPLapointeBTetrodotoxin for moderate to severe cancer pain: a randomized, double blind, parallel design multicenter studyJ Pain Symptom Manage200835442042918243639
   PubMed Web of Science ®Google Scholar
• WangXMHamzaMWuTXDionneRAUpregulation of IL-6, IL-8 and CCL2 gene expression after acute inflammation: correlation to clinical painPain2009142327528319233564
   PubMed Web of Science ®Google Scholar
• UceylerNKafkeWRiedigerNElevated proinflammatory cytokine expression in affected skin in small fiber neuropathyNeurology201074221806181320513817
   PubMed Web of Science ®Google Scholar
• WangXMLehkyTJBrellJMDorseySGDiscovering cytokines as targets for chemotherapy-induced painful peripheral neuropathyCytokine20125913922537849
   PubMed Web of Science ®Google Scholar
• GinhouxFGreterMLeboeufMFate mapping analysis reveals that adult microglia derive from primitive macrophagesScience2010330600584184520966214
   PubMed Web of Science ®Google Scholar
• NimmerjahnAKirchhoffFHelmchenFResting microglial cells are highly dynamic surveillants of brain parenchyma in vivoScience200530857261314131815831717
   PubMed Web of Science ®Google Scholar
• TsudaMTozaki-SaitohHInoueKPurinergic system, microglia and neuropathic painCurr Opin Pharmacol2012121747922036170
   PubMed Web of Science ®Google Scholar
• ChengKIWangHCChuangYTPersistent mechanical allodynia positively correlates with an increase in activated microglia and increased P-p38 mitogen-activated protein kinase activation in streptozotocin-induced diabetic ratsEur J Pain201418216217323868758
   PubMed Web of Science ®Google Scholar
• KolesnickRThe therapeutic potential of modulating the ceramide/sphingomyelin pathwayJ Clin Invest200211013812093880
   PubMed Web of Science ®Google Scholar
• SalveminiDDoyleTKressMNicolGTherapeutic targeting of the ceramide-to-sphingosine 1-phosphate pathway in painTrends Pharmacol Sci201334211011823318139
   PubMed Web of Science ®Google Scholar
• BennettGJPathophysiology and animal models of cancer-related painful peripheral neuropathyOncologist201015Suppl 291220489191
   PubMed Web of Science ®Google Scholar
• DworkinRHBackonjaMRowbothamMCAdvances in neuropathic pain: diagnosis, mechanisms, and treatment recommendationsArch Neurol200360111524153414623723
   PubMed Web of Science ®Google Scholar
• McNicolEHorowicz-MehlerNFiskRAManagement of opioid side effects in cancer-related and chronic noncancer pain: a systematic reviewJ Pain20034523125614622694
   PubMed Web of Science ®Google Scholar